Sanket Koul

India's pharmaceutical exports to the US are unlikely to see major tariff changes under the interim pact as Section 232 investigations continue, though medical devices may gain from better access

Industry executives note that REITs raise debt by issuing securities subscribed to by mutual funds and non-banking financial companies (NBFCs)

India's higher education sector could require nearly 30,000 acres of new campus land and 2.7 billion sq ft of academic infrastructure by 2035, driven by rising enrolments and policy ambitions

Max Healthcare's Q3 profit rose 26% on higher occupancies and overseas patients, even as margins narrowed due to regulatory changes and expansion costs

Draft amendment seeks mandatory reporting of manufacturing and quality changes to drug regulator

Depreciation, finance costs from new Noida facility and one-time labour code impact weigh on December-quarter profit

Targeted housing under BLC component raised from 111,000 to 500,000 homes in FY27

Younger demography, infra potential prime India's push to be most strategic higher education growth market globally

Mankind Pharma posted a 9.5 per cent rise in Q3FY26 net profit and 11.5 per cent growth in revenue, driven by strong domestic demand for chronic therapies

FY27 PLI scheme allocation rises 2.24%, aiming to add 500 MT to domestic API production

The health ministry is targeting a sharp rise in hospital admissions and claims disbursal under PMJAY in FY27, even as the Budget provides only a marginal increase in the scheme's overall allocation

Industry executives say the Budget's focus on data centres, city economic regions and infrastructure funding for tier 2 and 3 cities could spur demand across industrial, warehousing, office and reside

Biopharma Shakti initiative to tackle burden of non-communicable diseases, turn India into global, innovation-led hub

School education and learning receive their highest-ever allocation as Budget 2026-27 raises overall education spending by over 8 per cent, with higher outlays for KVs, IITs and new initiatives

Finance Minister Nirmala Sitharaman announced Mission Biopharma Shakti in the Budget, a five-year ₹10,000 crore programme to build domestic capabilities in biologics, biosimilars and clinical research

Health Ministry proposes listing Navi Mumbai International Airport as a notified port under drug rules, enabling air import of medicines through the facility

Diagnostics major reports a one-time charge linked to new labour codes even as revenue rose over 10% on higher sample volumes and network expansion

US technology major leases space at Tata Realty's Intellion Park as demand for offices in tier-I cities stays strong and absorption continues to outpace new supply

Economic Survey flags rising lifestyle diseases and obesity in India, urging stricter regulation and warning labels on ultra-processed foods to curb health risks

Centre imposes one-year minimum import price on key penicillin inputs to check Chinese dumping and protect domestic bulk drug manufacturing